HKSE - Delayed Quote HKD
HBM Holdings Limited (2142.HK)
As of 1:11 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,122.000
-19,122.000
-99,964.000
-125,609.000
-35,387.000
Investing Cash Flow
28,087.000
28,087.000
137,590.000
-76,903.000
-93,534.000
Financing Cash Flow
-29,143.000
-29,143.000
70,575.000
1,589.000
357,860.000
End Cash Position
140,324.000
140,324.000
161,705.000
56,304.000
256,794.000
Capital Expenditure
-2,480.000
-2,480.000
-18,438.000
-14,202.000
-603.000
Issuance of Capital Stock
-354.000
-354.000
-753.000
-8,115.000
367,726.000
Issuance of Debt
11,426.000
11,426.000
77,491.000
12,040.000
--
Repayment of Debt
-35,211.000
-35,211.000
-1,352.000
--
--
Free Cash Flow
-21,602.000
-21,602.000
-118,402.000
-139,811.000
-35,990.000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1228.HK CANBRIDGE-B
0.260
+7.88%
2179.HK Jiangsu Recbio Technology Co., Ltd.
8.280
-1.43%
2616.HK CStone Pharmaceuticals
1.970
-3.90%
1801.HK INNOVENT BIO
39.000
-1.39%
IMVT Immunovant, Inc.
29.42
+0.10%
ARGX.BR argenx SE
542.80
-1.60%
KRYS Krystal Biotech, Inc.
170.85
-3.14%
TSHA Taysha Gene Therapies, Inc.
1.3400
-12.42%
DNLI Denali Therapeutics Inc.
27.21
+0.59%
ARGX argenx SE
588.67
-1.16%